<DOC>
	<DOC>NCT02260284</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficiency and safety of Acupotome in Treating Ankylosing Spondylitis.</brief_summary>
	<brief_title>The Effect of Acupotome in Treating Ankylosing Spondylitis</brief_title>
	<detailed_description />
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis, Ankylosing</mesh_term>
	<criteria>Eligible adult (≥18 years of age) patients Had a diagnosis of AS for at least 3 months defined as definite by the 1984 modified New York criteria Eligible patients also had a Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) of ≥4 (010 cm scale) A visual analogue scale (VAS) score for total back pain of ≥4 (010 cm scale) Had received prior acupotome therapy With complete ankylosis of the spine, defined as the presence of bridging syndesmophytes at all intervertebral levels of the cervical and lumbar spine on lateral view spinal radiographs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>